Anesthesia is a medical term that means insensitivity to pain. Anesthesia is widely used during surgical procedures to bring unconsciousness to patients. Anesthesia vaporizers are devices that convert liquid inhalation agents into vapors. This vapor and oxygen are collectively delivered to the patient via inhalation route, primarily during pre-surgical procedures. An anesthesia delivery system typically consists of a machine that contains a breathing circuit. The necessity of these devices depends on the type of surgery performed. The concentration of dose differs in every case.
With advancements in surgical procedures and technological improvements, the average life expectancy of individuals has increased significantly. Rise in the geriatric population worldwide is amongst the important drivers of the global anesthesia vaporizers market. The reasons behind them are, the geriatric population is highly prone to the degenerative diseases, infections and chronic illnesses which ultimately results in an increased in incidences of surgeries and therapeutics, as ageing peoples lacks immunity to fight against them. This requires continuous monitoring, which propels the global anesthesia vaporizers market. Newly developed anesthesia vaporizer devices come with an advanced decision-support system (DSS), which also supports the monitoring capabilities; for instance, end-tidal concentrations of carbon dioxide and oxygen, inhalation anesthetics, and transcutaneous oxygen saturation. These advancements provide data analysis to clinicians and surgeons, which can help them take decisions during surgical procedures or other therapeutic treatments. Consequently, a few of the side-effects involved such as cognitive disturbances and post-operative delirium related to anesthesia, primarily in elderly patients, act as restraints for the market. Rise in the cost of surgical procedures and instruments and poor reimbursement policies are also important factors likely to hamper the global anesthesia vaporizers market during the forecast period.
The global anesthesia vaporizers market can be segmented on the basis of product, agent specificity, and end-user. Based on product, it can be segmented into plenum vaporizers and drawover vaporizers. Based on agent specificity, the anesthesia vaporizers market can be segmented into agent-specific and multiple agents. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, clinics, and nursing homes. Rise in the number of hospitals, clinics, ambulatory surgical centers, and nursing homes and the availability of advanced infrastructure are a few factors responsible for growth of the anesthesia vaporizers market. Additionally, presence of skilled personnel in hospitals has significantly fueled the anesthesia vaporizers market.
Geographically, the global anesthesia vaporizers market has been segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America is a major market for anesthesia vaporizers, due to the rising number of surgeries in the region led by elevated awareness amongst surgeons about the benefits of anesthesia devices. Additionally, with widespread technological advancements and increasing competition in the market, demand for superior technological advancements for better results has been increasing. The market in Asia Pacific is anticipated to witness high growth during the forecast period, increased awareness about health care, unmet needs of the large population, rapidly developing health care network, rise in the disposable income, and favorable reimbursement policies in the region. These factors have also made the practice of advanced techniques in anesthesia monitoring easier in the region.
Major players operating in the global anesthesia vaporizers market are Drägerwerk, GE Healthcare, Penlon, Meditec International England, Oricare, Spacelabs Healthcare, Beijing Siriusmed Medical Device, Baxter International, Inc., Intersurgical Limited, Medtronic, Inc., Mindray Medical International Limited, Nihon Kohden Corporation, Philips Healthcare, and Smiths Medical, Inc. New collaborative developments and new product techniques are some of the strategic initiatives taken by the companies to remain in the competition.
Major players operating in the market are Biogen Idec, Inc., Bristol-Myers Squibb, Celgene Corporation, ERYTECH Pharma, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline Pharmaceuticals Limited, and Pfizer, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.